Literature DB >> 7904708

Exacerbation of type 2 diabetes mellitus during interferon-alfa therapy for chronic hepatitis B.

E P Lopes, P M Oliveira, A E Silva, M L Ferraz, C H Costa, W Miranda, S A Dib.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7904708     DOI： 10.1016/s0140-6736(94)91035-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C.

Authors:  B Wesche; E Jaeckel; C Trautwein; H Wedemeyer; A Falorni; H Frank; A von zur Mühlen; M P Manns; G Brabant
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

Review 2.  Dysglycaemias and fluoroquinolones.

Authors:  Roshan J Lewis; John F Mohr
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

3.  Glucose intolerance in Chinese patients with chronic hepatitis C.

Authors:  Liang-Kung Chen; Shinn-Jang Hwang; Shih-Tzer Tsai; Jiing-Chyuan Luo; Shou-Dong Lee; Full-Young Chang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.